Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There’s no denying that Jasper Therapeutics (NASDAQ: JSPR ) stock investors are in a good mood today. They’re clearly celebrating the announcement of Jasper’s Phase 1 data for briquilimab in the treat...
Ready To Buy Penny Stocks? Have You Looked At Stock Market News Today? If you’re looking for penny stocks to buy, you’re likely taking the first step by hunting for potential catalysts. Whether it’s the latest short squeeze or speculation-based move, traders want to be as...
Jasper Therapeutics ( NASDAQ: JSPR ) added ~30% pre-market Friday after announcing new data from a Phase 1 trial designed to evaluate its lead candidate briquilimab in a combination therapy for older adults with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). The ...
Three abstracts highlight the safety and efficacy of briquilimab combined with low-toxicity radiation conditioning to achieve full donor engraftment and leukemia disease eradication Data demonstrates that briquilimab is safe and well-tolerated as a conditioning agent in older patients...
Jasper Therapeutics ( NASDAQ: JSPR ) on Tuesday said it would focus on the development of its lead product candidate briquilimab as part of an overall portfolio prioritization. Shares of the clinical-stage biotech rose 17% to $1.86 after the opening bell. It is worth noting th...
REDWOOD CITY, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper” or the “Company”), a biotechnology company developing novel antibody therapies and stem cell transplant conditioning agents targeting c-Kit, today announced, as p...
Jasper Therapeutics ( NASDAQ: JSPR ) on Wednesday said a European drug regulator committee had granted an orphan drug designation to its monoclonal antibody as a conditioning treatment for patients before they get a stem cell transplant. The designation was granted by the European Med...
REDWOOD CITY, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on transforming the field of hematopoietic cell transplant (HCT) therapies, today announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Pro...
4 Mistakes Penny Stocks Traders Should Avoid This Year Trading penny stocks can be a risky but potentially rewarding venture, and it’s important for traders to be aware of common mistakes that can cost them money. Here are some of the biggest mistakes that traders should avoid when it ...
Cheap Stocks On Robinhood Moving On Tuesday Whether you call them cheap stocks, penny stocks, or lotto tickets, most day traders hunting for new opportunities typically include stocks under $5 on their list. Why? One of the biggest reasons is regarding how volatile low-priced stocks can be ...
News, Short Squeeze, Breakout and More Instantly...
Jasper Therapeutics Inc. Company Name:
JSPR Stock Symbol:
NASDAQ Market:
Jasper Therapeutics Inc. Website:
REDWOOD CITY, Calif., June 19, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneou...
REDWOOD CITY, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CS...
2024-06-16 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...